✦ LIBER ✦

7-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease

✍ Scribed by Elstein, Deborah; Crombez, Eric; Zahrieh, David; Wang, Nan; Zimran, Ari

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of long-term velaglu

✍ Giraldo, Pilar; Zimran, Ari; Mehta, Atul; Hughes, Derralynn; Hangartner, Thomas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Safety and Efficacy of Velaglucerase Alf

✍ Ari Zimran; Madhulika Kabra; Pilar Giraldo; Marie-Françoise Ben Dridi; Deborah E 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Impact of velaglucerase alfa on bone mar

✍ Elstein, Deborah; Haims, Andrew H.; Zahrieh, David; Cohn, Gabriel M.; Zimran, Ar 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Safety and efficacy of long-term enzyme

✍ Elstein, Deborah; Giraldo, Pilar; Mehta, Atul; Pastores, Gregory; Rhead, William 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 367 KB

A 7-year open-label study of clinical pa

✍ Elstein, Deborah; Cohn, Gabriel; Zahrieh, David; Crombez, Eric; Zimran, Ari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

49. Five-year safety and efficacy of vel

✍ Deborah Elstein; Ari Zimran; Gabriel M. Cohn; Kiran Bhirangi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB